KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancer

Authors:
  • NGNatalya V. Guseva
    Natalya V. Guseva
  • ATAgshin F. Taghiyev
    Agshin F. Taghiyev
  • RGRebecca A. Glover
    Rebecca A. Glover
  • MCMichael B. Cohen
    Michael B. Cohen

Abstract
It has been suggested that the down-regulation of AR expression should be considered the principal strategy for the treatment of hormone-refractory prostate cancer.We have previously shown that inh...